Haleon

In the current context, Haleon is a topic that has caught the attention of a large number of people around the world. Its relevance has been enhanced by a series of events that have aroused general interest and generated all kinds of debates and reflections. This article aims to delve into Haleon from different perspectives, analyzing its impact in different areas and exploring its long-term implications. Haleon is a topic that leaves no one indifferent and that deserves to be addressed in a detailed and rigorous manner to understand its scope and significance today.

Haleon plc
Company typePublic limited company
ISINGB00BMX86B70
Industry
Predecessors
Founded18 July 2022 (2022-07-18)
HeadquartersWeybridge, Surrey, England
Area served
Worldwide
Key people
Products
Brands
RevenueIncrease £11,302 million (2023)
Increase £1,996 million (2023)
Decrease £1,111 million (2023)
Total assetsDecrease £34,055 million (2023)
Total equityIncrease £16,729 million (2023)
Number of employees
24,000 (2023)
Websitewww.haleon.com

Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins. The company is a global leader in over the counter medicines with a 7.3 percent market share.

Haleon was established on 18 July 2022 as a corporate spin-off from GSK.

Sir David Lewis is chairman, with Brian McNamara as CEO. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020.

History

GSK and Pfizer merged their consumer healthcare businesses in 2019. GSK owned just over two thirds of the joint venture, and Pfizer held the remainder.

GSK announced plans to spin-off Haleon in 2018, in order to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division".

Unilever offered £50 billion for the business in 2022, in a bid which GSK rejected. Nestlé examined the possibility of a bid in conjunction with Reckitt.

In October 2023, GSK reduced its ownership share in Haleon to just over 7.4%, and again in January 2024 down to 4.2%.

The ChapStick lip care brand was sold to Yellow Wood Partners for £401 million in 2024.

In March 2024, Pfizer reduced its stake in Haleon from 32% to 24% by selling 630 million shares in a public offering.

In April 2024 Haleon announced that it planned to close its British factory in Maidenhead. Toothpaste manufacturing would be relocated to Slovakia, with mouthwash production outsourced to a third-party.

Operations

Oral health accounted for 28.5 percent of revenue in 2021.

Brands

A selection of Aquafresh toothpaste and toothbrushes produced by Haleon

Brands include:

  • Abreva (Docosanol)
  • Advil (Ibuprofen)
  • alli (Orlistat)
  • Anadin (pain relief)
  • Aquafresh (oral healthcare)
  • Astring-o-Sol (oral healthcare)
  • Be-Total (leader in vitamins market in Italy)
  • Beechams Cold & Flu and Night/Day Nurse (cold and flu treatments)
  • Biotene (oral healthcare)
  • Boost (nutritional)
  • Breathe Right (respiratory)
  • Centrum (vitamins and naturals)
  • Cetebe (vitamins and naturals)
  • Chlorhexamed (oral healthcare)
  • Cholinex (analgesics and respiratory tract)
  • Citrucel (gastrointestinal)
  • Coldrex (cold and flu treatment)
  • Commit Lozenge (smoking cessation)
  • Committed Quitters (nicotine replacement)
  • Corega (oral healthcare)
  • Corsodyl (oral healthcare)
  • Crocin (analgesics and respiratory tract)
  • Dr. Best (oral healthcare)
  • Emergen-C
  • ENO (gastrointestinal)
  • Eumovate (dermatological)
  • Excedrin
  • Fenistil
  • Fenbid (analgesics and respiratory tract)
  • Flonase (fluticasone propionate)
  • Foodles (noodles), origin: India
  • Formigran (analgesic/triptan)
  • Grand-PA (headache/toothache/pain and fever)
  • Hinds (dermatological)
  • Junior Horlicks (nutritional)
  • Imedeen
  • Iodex (pain relief)
  • Iodosan (cold and flu treatment)
  • Lamisil (terbinafine)
  • Macleans (oral healthcare)
  • Maltova (nutritional)
  • Maxinutrition (nutritional)
  • Med-Lemon (hot, cold and flu medication)
  • Medacalm (vitamins and naturals)
  • Nexium Control (esomeprazole)
  • Nicorette (nicotine replacement)
  • Nicotinell
  • Night Nurse (cold and flu remedy)
  • NiQuitin CQ/ Nicoderm CQ/ Nicabate (nicotine replacement)
  • Odol (oral healthcare)
  • Odol-med3 (oral healthcare)
  • Os-cal (oral healthcare)
  • Otrivin/Otrivine (xylometazoline)
  • Panadeine (analgesics and respiratory tract)
  • Panadol/Panodil (analgesics and respiratory tract)
  • parodontax (oral healthcare)
  • Piriton/Piriteze/Pirinase (anti-allergy)
  • Polident (oral healthcare)
  • Poligrip Ultra (oral healthcare)
  • Robitussin (respiratory)
  • Rutinoscorbin (vitamins and naturals)
  • Scott's Emulsion (vitamins and naturals)
  • Sensodyne (oral healthcare)
  • Shumitect (oral healthcare)
  • Solpadeine (analgesics and respiratory tract)
  • Super Poligrip (oral healthcare)
  • Super Wernet's (oral healthcare)
  • Synthol (oral healthcare)
  • Theraflu (Respiratory)
  • Tums (gastrointestinal)
  • Viva (vitamins and naturals), origin: Nepal
  • Voltaren/Voltarol (anti inflammatory)
  • Zovirax (dermatological)

References

  1. ^ a b c d e "Annual results 2023" (PDF). Haleon. Retrieved 29 February 2024.
  2. ^ "Haleon plots massive layoffs in UK and beyond to save costs: report". Fierce Pharma. 13 July 2023. Retrieved 11 February 2024.
  3. ^ "GSK announces independent Consumer Healthcare company is to be called Haleon | GSK". www.gsk.com. 22 February 2022. Retrieved 2023-02-21.
  4. ^ Ralph, Alex (2 July 2022). "GlaxoSmithKline prepares to get back to basics with historic break-up". The Times. Retrieved 4 July 2022.
  5. ^ a b Cornell, Joe (15 July 2021). "GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022". Forbes. Retrieved 10 June 2022.
  6. ^ "Prospectus" (PDF). GSK plc. p. 15. Retrieved 10 June 2022.
  7. ^ Kleinman, Mark (3 May 2022). "GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks". Sky News. Retrieved 10 June 2022.
  8. ^ a b Shane, Daniel (19 December 2018). "Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses". CNN. Retrieved 10 June 2022.
  9. ^ "Haleon Won't Indemnify Pfizer, GSK Over Zantac. Shares Are Up". Barron's. 20 September 2022. Retrieved 17 December 2022.
  10. ^ Donnellan, Aimee (9 June 2022). "GSK castoff starts life with target on its back". Reuters. Retrieved 10 June 2022.
  11. ^ Jolly, Jasper (19 January 2022). "Unilever will not increase £50bn offer for GSK consumer arm". The Guardian. Retrieved 10 June 2022.
  12. ^ "Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit". Bloomberg News. 25 May 2022. Retrieved 10 June 2022.
  13. ^ "GSK raises $1.1 billion from Haleon stake sale". Reuters. 2023-10-06. Retrieved 2023-10-09.
  14. ^ "GSK raises $1.24 bln from latest Haleon stake sale". Reuters. 2024-01-17. Retrieved 2024-01-18.
  15. ^ Williams, Holly (25 January 2024). "Haleon offloads ChapStick lip balm brand in £401m deal". The Standard. Retrieved 20 February 2024.
  16. ^ "Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%". Yahoo Finance. 2024-03-18. Retrieved 2024-03-19.
  17. ^ Briant, Nathan (30 April 2024). "Sensodyne maker set to cut 435 jobs". BBC News. Retrieved 8 May 2024.
  18. ^ Mathews, Eva (30 April 2024). "Sensodyne-maker Haleon to shut UK plant, 435 jobs to go". Reuters. Retrieved 8 May 2024.
  19. ^ "Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon". GSK. 6 January 2022. Retrieved 10 June 2022.
  20. ^ "Our Consumer Healthcare Brands". Haleon. Retrieved 19 July 2022.

External links

Wikious
Boobota
Sagapedia